Plus Therapeutics Inc (PSTV) — Capital Reinvestment Ratio

Latest as of December 2019: 0.06x

Plus Therapeutics Inc (PSTV) has a Capital Reinvestment Ratio of 0.06x as of December 2019, meaning it reinvests 0% of its operating cash flow ($1.04 Million) in capital expenditures ($59.00K). Check Plus Therapeutics Inc (PSTV) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

$1.04 Million

USD

Capital Expenditures

$59.00K

USD

Data as of

Dec 2019

Most recent filing

Annual Capital Reinvestment Ratio for Plus Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Plus Therapeutics Inc from None to None. See Plus Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow